Financials
- Market Capitalization 15.75 M
- Employee 142
- Founded 2001
- CEO Yaky Yanay
- Website www.pluri-biotech.com
- Headquarter Nevada, United States
- FIGI BBG000DQX509
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-1.16
市销率
24.98
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4627 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.07 USD | -1.83% | -2.73% | +20.22% | -55.23% | 15.84 M USD | ||
| 4635 | CTXR Citius Pharmaceuticals, Inc. - Common Stock | 0.58 USD | 0.00% | -4.92% | -1.69% | -55.38% | 15.92 M USD | ||
| 4638 | NCEL NewcelX Ltd. - Ordinary Shares | 3.24 USD | -1.22% | -5.81% | -10.25% | -36.22% | 15.54 M USD | ||
| 4646 | HIND Vyome Holdings, Inc. - Common Stock | 2.15 USD | -0.46% | -5.70% | +2.87% | -75.57% | 15.09 M USD |